These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 16618381)

  • 41. Preoperative therapy with concurrent paclitaxel/carboplatin/infusional 5-FU and radiation therapy in locoregional esophageal cancer: final results of a Minnie Pearl Cancer Research Network phase II trial.
    Meluch AA; Greco FA; Gray JR; Thomas M; Sutton VM; Davis JL; Kalman LA; Shaffer DW; Yost K; Rinaldi DA; Hainsworth JD
    Cancer J; 2003; 9(4):251-60. PubMed ID: 12967135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Current status of new drugs and multidisciplinary approaches in patients with carcinoma of the esophagus.
    Ajani JA
    Chest; 1998 Jan; 113(1 Suppl):112S-119S. PubMed ID: 9438700
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Treatment approach to localized esophageal cancer--what have we learned so far?].
    Brenner B; Purim O; Sulkes A
    Harefuah; 2005 Jul; 144(7):482-8, 526. PubMed ID: 16082900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High dose radiation with chemotherapy followed by salvage esophagectomy among patients with locally advanced esophageal squamous cell carcinoma.
    Lertbutsayanukul C; Tharavej C; Klaikeaw N; Prayongrat A; Lowanitchai C; Sriuranpong V
    Thorac Cancer; 2017 May; 8(3):219-228. PubMed ID: 28322515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of multimodality therapy for resectable esophageal cancer.
    Meneu-Diaz JC; Blazquez LA; Vicente E; Nuño J; Quijano Y; Lopez-Hervás P; Devesa M; Fresneda V
    Am J Surg; 2000 Jun; 179(6):508-13. PubMed ID: 11004342
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Management of esophageal cancer.
    Ilson DH; Kelsen DP
    Oncology (Williston Park); 1996 Sep; 10(9):1385-96, 1401-2; discussion 1402-8. PubMed ID: 8882928
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiotherapy in the multimodality management of esophageal cancer.
    Encheva E; Kolev N; Tonev A; Ignatov V; Shterev S; Petrov D; Zlatarov A; Koleva I; Chaushev B; Kirilova T; Ivanov K
    Khirurgiia (Sofiia); 2014; (3):12-9. PubMed ID: 25799618
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer.
    Courrech Staal EF; Aleman BM; Boot H; van Velthuysen ML; van Tinteren H; van Sandick JW
    Br J Surg; 2010 Oct; 97(10):1482-96. PubMed ID: 20645400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Toxicity of chemotherapy for esophageal carcinoma.
    Ilson D
    Chest Surg Clin N Am; 1997 Aug; 7(3):551-63; discussion 564. PubMed ID: 9246402
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of locoregional stage esophageal cancer: a single center experience.
    Javle MM; Nwogu CE; Donohue KA; Iyer RV; Brady WE; Khemka SV; Smith JL; Demmy TL; Yang GY; Nava HR
    Dis Esophagus; 2006; 19(2):78-83. PubMed ID: 16643174
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Final Results of NRG Oncology RTOG 0246: An Organ-Preserving Selective Resection Strategy in Esophageal Cancer Patients Treated with Definitive Chemoradiation.
    Swisher SG; Moughan J; Komaki RU; Ajani JA; Wu TT; Hofstetter WL; Konski AA; Willett CG
    J Thorac Oncol; 2017 Feb; 12(2):368-374. PubMed ID: 27729298
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extended survival time for esophageal cancer patients treated with aggressive surgery and concurrent chemoradiation.
    Saito T; Shigemitsu Y; Kinoshita T; Shimoda K; Katsuta T; Abe T; Chikuba K; Miyahara M; Kobayashi M
    Int Surg; 1994; 79(2):93-7. PubMed ID: 7928159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined modality therapy of localized gastric and esophageal cancers.
    Das P; Fukami N; Ajani JA
    J Natl Compr Canc Netw; 2006 Apr; 4(4):375-82. PubMed ID: 16569390
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Study on safety of adjuvant radiotherapy concurrent with weekly chemotherapy for stage ⅡB-ⅣA esophageal carcinoma after radical resection].
    Ni WJ; Yu SF; Yang JS; Zhang WC; Zhou ZM; Zhang HX; Chen DF; Feng QF; Lyu JM; Liang J; Wang XZ; Wang X; Deng L; Wang WQ; Zhang T; Bi N; Xiao ZF
    Zhonghua Zhong Liu Za Zhi; 2019 Jun; 41(6):415-420. PubMed ID: 31216826
    [No Abstract]   [Full Text] [Related]  

  • 55. [Current status of combined modality therapy for esophageal cancer: from the standpoint of medical oncology].
    Ohtsu A
    Gan To Kagaku Ryoho; 1998 Jan; 25(2):232-40. PubMed ID: 9474933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Concurrent paclitaxel and thoracic irradiation for locally advanced esophageal cancer.
    Blanke CD; Choy H; Teng M; Beauchamp RD; Leach S; Roberts J; Washington K; Johnson DH
    Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):43-52. PubMed ID: 10210539
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Esophageal cancer: did combined treatments improve prognosis?].
    Ganem G; Raoul Y; Goudier MJ; Dubray B; Colin P; Extra JM; Hennequin C; Michel-Langlet P; Vignoud J; Bardet E
    Bull Cancer; 1992; 79(8):735-50. PubMed ID: 1467597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Preoperative concurrent chemotherapy and radiation therapy followed by surgery for esophageal cancer.
    Yano M; Inoue M; Shiozaki H
    Ann Thorac Cardiovasc Surg; 2002 Jun; 8(3):123-30. PubMed ID: 12472392
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The current management of esophageal cancer.
    Law S; Wong J
    Adv Surg; 2007; 41():93-119. PubMed ID: 17972559
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Preoperative and adjuvant therapies for upper gastrointestinal cancers.
    Varadhachary G; Ajani JA
    Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.